Form 8-K - Current report:
SEC Accession No. 0000831547-20-000039
Filing Date
2020-05-07
Accepted
2020-05-07 16:17:07
Documents
16
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sppi-20200507.htm   iXBRL 8-K 42801
2 EX-99.1 exhibit99120200331.htm EX-99.1 213462
8 SPECTRUM LOGO logospectruma171.jpg GRAPHIC 21505
  Complete submission text file 0000831547-20-000039.txt   450376

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sppi-20200507.xsd EX-101.SCH 2571
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sppi-20200507_cal.xml EX-101.CAL 718
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sppi-20200507_def.xml EX-101.DEF 1655
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sppi-20200507_lab.xml EX-101.LAB 25293
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sppi-20200507_pre.xml EX-101.PRE 13198
11 EXTRACTED XBRL INSTANCE DOCUMENT sppi-20200507_htm.xml XML 11259
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

EIN.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35006 | Film No.: 20856658
SIC: 2834 Pharmaceutical Preparations